Jay Oza

735 total citations
14 papers, 596 citations indexed

About

Jay Oza is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jay Oza has authored 14 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jay Oza's work include Sarcoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Jay Oza is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Jay Oza collaborates with scholars based in United States, Sweden and Netherlands. Jay Oza's co-authors include Shridar Ganesan, Atul Kulkarni, Vasudeva Ginjala, Ming Yao, Maarten van Lohuizen, Karim Nacerddine, Sarah J. Hill, Elisabetta Citterio, Ming Yao and Gyan Bhanot and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Jay Oza

14 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay Oza United States	9	488	195	125	89	32	14	596
R. Habets Netherlands	8	357 0.7×	161 0.8×	178 1.4×	56 0.6×	32 1.0×	8	535
Ritu Kulshrestha India	10	432 0.9×	290 1.5×	119 1.0×	95 1.1×	26 0.8×	35	647
Ya‐Ping Tsai Taiwan	6	371 0.8×	243 1.2×	120 1.0×	49 0.6×	42 1.3×	6	515
Shuliang Zhao China	13	293 0.6×	146 0.7×	88 0.7×	112 1.3×	29 0.9×	21	469
Qing-Shan Wang China	9	344 0.7×	136 0.7×	174 1.4×	51 0.6×	23 0.7×	10	462
Janét Pittsenbarger United States	6	245 0.5×	134 0.7×	101 0.8×	98 1.1×	14 0.4×	11	389
Julian Musa Germany	8	334 0.7×	136 0.7×	113 0.9×	108 1.2×	42 1.3×	18	500
Jian‐Liang Chou Taiwan	11	333 0.7×	118 0.6×	72 0.6×	46 0.5×	28 0.9×	21	480
Carlise R. Bethel United States	7	316 0.6×	132 0.7×	79 0.6×	203 2.3×	21 0.7×	7	444
Kaushal Asrani United States	12	227 0.5×	117 0.6×	114 0.9×	119 1.3×	37 1.2×	17	408

Countries citing papers authored by Jay Oza

Since Specialization

Citations

This map shows the geographic impact of Jay Oza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Oza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Oza more than expected).

Fields of papers citing papers by Jay Oza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Oza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Oza. The network helps show where Jay Oza may publish in the future.

Co-authorship network of co-authors of Jay Oza

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Oza. A scholar is included among the top collaborators of Jay Oza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Oza. Jay Oza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ingham, Matthew, Shing M. Lee, Brian A. Van Tine, et al.. (2022). A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical Cancer Research. 29(6). 1031–1039. 8 indexed citations

Coté, Gregory M., Edwin Choy, Katherine A. Thornton, et al.. (2022). A phase 1b lead-in to a randomized phase 2 trial of lurbinectedin plus doxorubicin in leiomyosarcoma (LMS).. Journal of Clinical Oncology. 40(16_suppl). TPS11592–TPS11592. 1 indexed citations

Oza, Jay, Brittany L. Siontis, Benjamin Powers, et al.. (2021). A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.. Journal of Clinical Oncology. 39(15_suppl). TPS11578–TPS11578. 5 indexed citations

Oza, Jay, Brian Andrew Van Tine, Edwin Choy, et al.. (2021). A phase II trial of sitravatinib, a multireceptor tyrosine kinase inhibitor, in patients with advanced well-differentiated/dedifferentiated liposarcoma.. Journal of Clinical Oncology. 39(15_suppl). 11513–11513. 2 indexed citations

Oza, Jay, et al.. (2021). Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated Sarcoma. JCO Precision Oncology. 5(5). 1–5. 8 indexed citations

Oza, Jay, et al.. (2020). Homologous recombination repair deficiency as a therapeutic target in sarcoma. Seminars in Oncology. 47(6). 380–389. 29 indexed citations

Rizk, Emanuelle M., Robyn D. Gartrell, Jay Oza, et al.. (2019). Nivolumab for hepatocellular carcinoma (HCC) in a real-world context.. Journal of Clinical Oncology. 37(15_suppl). e15675–e15675. 5 indexed citations

Oza, Jay, et al.. (2016). A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response. Journal of Biological Chemistry. 291(44). 22881–22893. 12 indexed citations

Kulkarni, Atul, Jay Oza, Ming Yao, et al.. (2013). Tripartite Motif-containing 33 (TRIM33) Protein Functions in the Poly(ADP-ribose) Polymerase (PARP)-dependent DNA Damage Response through Interaction with Amplified in Liver Cancer 1 (ALC1) Protein. Journal of Biological Chemistry. 288(45). 32357–32369. 54 indexed citations

10.

Ginjala, Vasudeva, Karim Nacerddine, Atul Kulkarni, et al.. (2011). BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair. Molecular and Cellular Biology. 31(10). 1972–1982. 207 indexed citations

11.

Ganesan, Shridar, Vassiliki Karantza, Jay Oza, & Deborah Toppmeyer. (2011). Triple-negative breast cancers and the human mammary epithelial cell hierarchy. Breast Disease. 32(1-2). 49–61. 1 indexed citations

12.

Liu, Huiqing, A. Rose Brannon, Anupama Reddy, et al.. (2010). Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Systems Biology. 4(1). 51–51. 205 indexed citations

13.

Oza, Jay, Jingxian Yang, Kuang Yu Chen, & Alice Y.‐C. Liu. (2008). Changes in the regulation of heat shock gene expression in neuronal cell differentiation. Cell Stress and Chaperones. 13(1). 73–84. 25 indexed citations

14.

Yang, Jingxian, et al.. (2008). Neural differentiation and the attenuated heat shock response. Brain Research. 1203. 39–50. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact